Every financial statement,
one clean chart.
Search any US-listed company. Data straight from SEC filings.
Xilio Therapeutics, Inc. (XLO), most recent 12 months reported: revenue $9.27M, net loss $54.3M, free cash flow -$18.41M. Latest balance sheet on file: liquid cash $89.07M. From SEC filings. Others in Pharmaceutical Preparations: Zenas BioPharma, Inc. · Opus Genetics, Inc. · PRECIGEN, INC. · INTERNATIONAL STEM CELL CORPORATION · Aclaris Therapeutics, Inc. · Coya Therapeutics, Inc. · Adagene Inc. · ROIVANT SCIENCES LTD.
Filter every US company by the numbers — net cash, margins, ROIC, growth. Looking for one company? The search box above is free.
Follow a company and we'll email you when it files a quarterly or annual report with the SEC. Free follows 3 companies; Pro follows up to 500, and sorts and filters them.